NLS Pharmaceutics Ltd (NLSP)

1.920 -0.46 (-19.33%) USD  |  NASDAQ  |  Dec 20, 16:00
1.95 +0.03 (+1.57%) After-Hours: 20:00
More

NLS Pharmaceutics Enterprise Value: 8.486M for Dec. 20, 2024

Enterprise Value Chart

View Enterprise Value for NLSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Enterprise Value Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Enterprise Value Definition

View Enterprise Value Definition
Start Trial

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks
Start Trial
AC Immune SA 77.48M
CRISPR Therapeutics AG 1.540B
Addex Therapeutics Ltd 4.458M
Molecular Partners AG 16.42M
MoonLake Immunotherapeutics 2.803B

Enterprise Value Related Metrics

Earnings Yield -351.1%